Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Bywrongon Jun 03, 2017 12:43pm

237 Views

Post# 26320634

Phase 11 FDA

An investor forum sends me market tidbits and one was about TLT and had a quote from Roger about FDA phase 11 clinical trial. When is that scheduled to start and who is paying for that? My understanding of FDA Ph 11 trials, they are double blind placebo/treatment trials. Can cost a whack of cash.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec